Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Tolvaptan
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Tolvaptan Jinarc
®
/ Teva
(15/45mg, 30/60mg, 30/90mg tablets)
Endocrine system, Antidiuretic hormone antagonists, 06.05.02
RED
Tolvaptan Samsca
®
(7.5mg, 15mg, 30mg Tablets)
Endocrine system, Antidiuretic hormone antagonists, 06.05.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Tolvaptan
Tolvaptan
Endocrine System, Antidiuretic Hormone Disorders, Syndrome Of Inappropriate Antidiuretic Hormone Secretion, Diuretics Selective Vasopressin V2-Receptor Antagonists
Tolvaptan
Tolvaptan
Genito-Urinary System, Kidney Disorders, Diuretics Selective Vasopressin V2-Receptor Antagonists
Links found
JPC bulletin 261: Tolvaptan (Samsca® Brand) tablets for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients not requiring chemotherapy (March 18)
NHS England: Tolvaptan for hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in patients requiring cancer chemotherapy
NICE TA358: Tolvaptan for treating autosomal dominant polycystic kidney disease